Navigation Links
Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009
Date:3/26/2009

BETHESDA, Md., March 26 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that its President and CEO, Dr. Christian Itin, will present at the Future Leaders in the Biotech Industry conference at the Millennium Broadway Hotel & Conference Center in New York City on Thursday, April 2, 2009. A simultaneous webcast of the presentation will be available on the company's website at www.micromet-inc.com

    Forum:      Future Leaders in the Biotech Industry
    Date:       Thursday, April 2, 2009
    Time:       1:30 to 1:55 pm U.S. Eastern Time
    Place:      The Millennium Broadway Hotel & Conference Center
                New York City, New York
    Webcast:    www.micromet-inc.com

About Micromet

Micromet, Inc. (www.micromet-inc.com) is a biopharmaceutical company with offices in Bethesda, MD and Munich, Germany. The Company is focused on developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. The Company's novel antibody technology is based on its proprietary BiTE(R) antibody platform, representing a new class of antibodies that specifically activate T cells from the patient's own immune system to eliminate cancer cells or other disease related cells. Four of the Company's antibodies are currently in clinical trials, with the remainder of its product pipeline in preclinical development. The Company's lead program is a BiTE antibody known as blinatumomab, or MT103. It is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia and a phase 1 cli
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics
2. Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research
3. Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008
4. Micromet to Present at the Cowen Health Care Conference on March 17, 2009
5. Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
6. Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009
7. Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG
8. Micromet to Present at the RBC Capital Markets Healthcare Conference
9. Micromet Added to NASDAQ Biotechnology Index
10. Micromet, Inc. Reports Third Quarter 2008 Financial Results
11. Micromet, Inc. to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... Houston, Texas (PRWEB) April 23, 2015 ... patient’s True Flow (blood flow through the device) in ... provided by Numerex, the world’s leading provider of Machine ... IoT. , True Flow via VADLink.com ... if there is any drop in flow below a ...
(Date:4/22/2015)... -- Sangamo BioSciences, Inc. (NASDAQ: SGMO ) today reported ... For the first quarter ended March 31, 2015, ... or $0.08 per share, compared to a net loss ... same period in 2014. As of March 31, 2015, ... interest receivable of $226.1 million. Revenues for ...
(Date:4/22/2015)... 22, 2015 Today, DuPont announced ... a leading microbiome discovery company. This acquisition will ... access in both seed and crop protection to ... globally. , “In 2014, the businesses in ... segments sold more than $1 billion in biological ...
(Date:4/22/2015)... Over the last five years, ... growth primarily due to growth in the ... increased nanotechnology R&D expenditure and increased international ... http://www.marketsandmarkets.com/requestCustomization.asp?id=65048077 , In this report, the ... on the basis of products and applications. ...
Breaking Biology Technology:Sangamo BioSciences Reports First Quarter 2015 Financial Results 2Sangamo BioSciences Reports First Quarter 2015 Financial Results 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 4Sangamo BioSciences Reports First Quarter 2015 Financial Results 5Sangamo BioSciences Reports First Quarter 2015 Financial Results 6Sangamo BioSciences Reports First Quarter 2015 Financial Results 7Sangamo BioSciences Reports First Quarter 2015 Financial Results 8DuPont Acquires Taxon Biosciences, Inc. 2DuPont Acquires Taxon Biosciences, Inc. 3DuPont Acquires Taxon Biosciences, Inc. 4Nanotechnology-based Medical Devices Market to Reach Around $8.5 billion by 2019 - Published by MarketsandMarkets 2Nanotechnology-based Medical Devices Market to Reach Around $8.5 billion by 2019 - Published by MarketsandMarkets 3
... API Software, Inc. announced today ... implement the majority of APIs suite of labor ... The solution will include Payrollmation time and attendance, ... human resources software. , ,The hospital is adopting ...
... Network Health Plan , Affinity Health Systems health plan ... today the availability of new online services for NHPs ... Internet-based health management system. , ,NHP will launch the ... member portals. Starting this summer, NHPs providers will be ...
... swing a golf club with one arm, or to write a ... would you? Or, at the very least, progress would be painfully ... human embryonic stem cells, the bodys core cells that can grow ... of embryonic stem cell research have turned out to be much ...
Cached Biology Technology:Lifting federal limits on stem cell research would speed search for cures 2Lifting federal limits on stem cell research would speed search for cures 3
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial ... Valley to implant a new miniaturized, wireless monitoring sensor ... is the first and only FDA-approved heart failure monitoring ... admissions when used by physicians to manage heart failure. ... that is implanted in the pulmonary artery (PA) during ...
(Date:4/14/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® smart ... Design Awards under the category  ,Product Design – Technology,. ... are part of a global multi-disciplinary awards program. The ... marketplace, industry and judging panel. Winners will be announced ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... 23, 2015, after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2
... a landscape susceptible to invasion by alien plant species, ... contributing to the accelerating spread of exotic aquatic species, ... issue of BioScience. John A. Havel of Southwest Missouri ... Vander Zanden of the University of Wisconsin survey evidence ...
... multiple complex biological interactions in a yeast cell in ... the networks of interaction by which components of a ... Open Access journal Journal of Biology shows that such ... predictions about interactions that haven't been observed experimentally. , ...
... just can't tell where you might find love these ... and a social psychologist found love-related neurophysiological systems inside ... responses in the brains of 17 young men and ... madly in love. , The multidisciplinary team found that ...
Cached Biology News:Reservoirs may accelerate the spread of invasive aquatic species, researchers say 2Navigating an integrated yeast network 2Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 2Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 3Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 4Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 5Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 6
Rabbit polyclonal to GABA A Receptor gamma 2 ( Abpromise for all tested applications). entrezGeneID: 2566 SwissProtID: P18507...
Rabbit polyclonal to VPAC2 ( Abpromise for all tested applications). entrezGeneID: 7434 SwissProtID: P41587...
Anti-GOSR2 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunocytochemistry, Immunoprecipitation, Western Blot...
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
Biology Products: